Three-year survival in stage IV non-small cell lung cancer (NSCLC): The importance of metastatic distribution

被引：0
|
作者：
Karp, Daniel D. [1 ]
Hanneken, Jan M. [1 ]
Taylor, Sarah H. [1 ]
Men, Taoyan [1 ]
Wu, Xifeng [1 ]
Pu, Xia [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7608
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Distribution of Metastatic Disease in Survival Outliers with Stage IV Non-Small Cell Lung Cancer
    Fung, A.
    D'Silva, A.
    Li, H.
    Otsuka, S.
    Bebb, D. G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2077 - S2078
  • [2] Impact of Metastatic Location on Survival in Stage-IV Non-Small Cell Lung Cancer (NSCLC) Treated with Immunotherapy
    Naqash, A. R.
    Jonnalagadda, S.
    Macherla, S.
    Polsani, S.
    Muzaffar, M.
    Cherry, C.
    Karim, N. Abdel
    Walker, P.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S464 - S464
  • [3] Clinicopathologic Characteristics And Predictors Of Survival In Stage Iv Non-Small Cell Lung Cancer (nsclc)
    Duma, N.
    Listo, M.
    Osorio, C.
    Zhang, S.
    Kang, M.
    Abu-Ihweij, K.
    Harper, H.
    Gutierrez, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [4] STAGE DISTRIBUTION AT DIAGNOSIS OF NON-SMALL CELL LUNG CANCER (NSCLC) AND GEOGRAPHIC VARIATION IN SURVIVAL
    Chikermane, S.
    Johnson, M. L.
    [J]. VALUE IN HEALTH, 2019, 22 : S58 - S58
  • [5] Three-year survival after combined treatment with induction chemoimmunotherapy in patients (pts) with non-small cell lung cancer (NSCLC).
    Lazutin, Yuriy N.
    Pyltsin, Sergey P.
    Kharitonova, Anna Pavlovna
    Ayrapetova, Tamara G.
    Leyman, Igor A.
    Chubaryan, Anna V.
    Anistratov, Pavel A.
    Shogenov, A. S.
    Gappoeva, M. A.
    Afaunov, M. Kh.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Treatment tolerance and survival in elderly patients with stage IV non-small cell lung cancer (NSCLC)
    Gijtenbeek, Rolof G. P.
    Helfrich, Gea
    Venmans, Ben J. W.
    Ten Brinke, Anneke
    De Jong, Kim
    Van Geffen, Wouter H.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [7] SPIROMETRY IN PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER (NSCLC)
    Mendis, R.
    McDonald, C. F.
    John, T.
    O'Donoghue, F. J.
    White, S. C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S75 - S75
  • [8] Extending Survival of Stage IV Non-Small Cell Lung Cancer
    Carnio, Simona
    Novello, Silvia
    Mele, Teresa
    Levra, Matteo Giaj
    Scagliotti, Giorgio Vittorio
    [J]. SEMINARS IN ONCOLOGY, 2014, 41 (01) : 69 - 92
  • [9] Is survival improving in stage IV non-small cell lung cancer?
    Birnbaum, A. E.
    Ng, T.
    O'Connor, B.
    Plette, A.
    Berz, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [10] PLATINUM BASED CHEMOTHERAPY IN STAGE IIIB AND IV NON-SMALL CELL LUNG CANCER (NSCLC) - THE EFFECT ON SURVIVAL
    Mobarek, N. A.
    [J]. LUNG CANCER, 2009, 64 : S57 - S57
12345